Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Rainbow Coral Corp. (RBCC) Signs JV Agreement With Cutting-Edge Drug Delivery Company 0 comments
    Mar 20, 2013 10:50 AM | about stocks: RBCC

    Today before the opening bell, the biotech division of Rainbow Coral announced it has formed a Joint Venture (JV) with TheraKine to solve the problems presented by systemic drug delivery. The new JV is an extension of the company's bold expansion into the $60 billion global drug delivery market.

    TheraKine is the developer of a revolutionary, sustained-release drug delivery platform that could soon make local delivery of biologic agents and small molecules safer, more effective, and more convenient than ever before. The company has developed and patented these novel, tunable technologies with the potential to enable selective, site-specific drug delivery, allowing for lower drug concentrations and significantly reducing the risk of drug toxicity.

    According to today's release, this new sustained-release technology can also extend the patent life cycles of drugs. Offering pharmaceutical and biotech companies extended patent protection represents a tremendous market advantage and opportunity to increase profitability of FDA-approved drugs.

    "TheraKine's sustained-release delivery system could allow patients who now need daily injections to instead have one injection every four to six months," stated RBCC CEO Patrick Brown. "We expect the demand for this product to be very high once it's made available, and RBCC plans to take a real stake in its success."

    Stan Yakatan, TheraKine's CEO, commented, "TheraKine is excited about the opportunity to partner with Rainbow to repurpose drugs with our sustained release technologies."

    For more information, visit rainbowbiosciences.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: RBCC
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.